Potassium Calculator
Electrophysiological Architecture and Body Distribution of Potassium
Potassium (K+) is the primary intracellular cation in the human body, serving as the master electrochemical determinant of the resting membrane potential across all excitable cellular membranes (cardiac myocytes, skeletal muscle fibers, and central/peripheral neurons). The human adult body contains approximately 3,500 milliequivalents (mEq) (~137 grams) of potassium, tightly partitioned into distinct compartments:
- Intracellular Fluid Compartment (~98% / ~3,430 mEq): Maintained at high concentration (140 to 150 mEq/L) inside the cytosol of skeletal muscle (holding ~75% of total body potassium), liver cells, erythrocytes, and bone.
- Extracellular Fluid Compartment (~2% / ~70 mEq): Maintained within a narrow physiological serum concentration of 3.5 to 5.0 mEq/L (mmol/L).
- The Na+/K+-ATPase Pump: This ubiquitous electrogenic translocase hydrolyzes 1 ATP molecule to actively pump 3 Na+ ions out of the cell in exchange for 2 K+ ions in. This creates the steep transmembrane chemical gradient that drives the resting membrane potential (Em ≈ −90 mV in cardiac myocytes), described by the Goldman-Hodgkin-Katz and Nernst equations.
NASEM Dietary Reference Intakes and WHO Guidelines
The National Academies of Sciences, Engineering, and Medicine (NASEM) and the World Health Organization (WHO) establish dietary potassium targets (Adequate Intake, AI) based on blood pressure regulation, stroke risk reduction, and kidney stone prevention:
| Demographic Category | Age / Life Stage | NASEM Adequate Intake (AI) | Millimoles / Milliequivalents | Primary Health Endpoints |
|---|---|---|---|---|
| Infants | 0 – 6 months | 400 mg/day | 10.2 mEq/day | Maintains neonatal somatic growth and cellular osmolarity. |
| Infants | 7 – 12 months | 860 mg/day | 22.0 mEq/day | Supports neuromuscular expansion during solid food transition. |
| Children | 1 – 3 years | 2,000 mg/day | 51.2 mEq/day | Establishes healthy baseline arterial elasticity. |
| Children | 4 – 8 years | 2,300 mg/day | 58.8 mEq/day | Promotes normal renal solute clearance. |
| Adolescent Males | 14 – 18 years | 3,000 mg/day | 76.7 mEq/day | Compensates for rapid skeletal muscle mass expansion. |
| Adolescent Females | 14 – 18 years | 2,300 mg/day | 58.8 mEq/day | Maintains normotensive vascular reactivity. |
| Adult Males | 19+ years | 3,400 mg/day | 87.0 mEq/day | Reduces systolic blood pressure; prevents stroke and calcium nephrolithiasis. |
| Adult Females | 19+ years | 2,600 mg/day | 66.5 mEq/day | Optimizes cardiovascular endothelial function and bone mineral density. |
| Pregnant Females | 19+ years | 2,900 mg/day | 74.2 mEq/day | Expands plasma volume while blunting gestational hypertensive risk. |
| Lactating Females | 19+ years | 2,800 mg/day | 71.6 mEq/day | Replenishes potassium secreted into maternal breast milk. |
| WHO Global Target (Hypertension) | All Adults | ≥ 3,510 mg/day | ≥ 90.0 mEq/day | Global public health target to lower stroke and coronary morbidity. |
The Sodium-to-Potassium Ratio (^+:K^+$) and Vascular Biology
Modern nutritional science recognizes that the molar ratio of dietary sodium to potassium is a more powerful predictor of cardiovascular disease and all-cause mortality than sodium intake alone:
Sodium (mEq) = Sodium Intake (mg) / 23.0
Potassium (mEq) = Potassium Intake (mg) / 39.1
Molar Ratio = Sodium (mEq) / Potassium (mEq)
• Evolutionary Hunter-Gatherer Ratio: < 0.25 (Very low sodium, extremely high potassium).
• Cardiovascular Optimal Target: ≤ 1.0 molar ratio (or < 0.6 mg:mg weight ratio).
• Typical Modern Western Diet: > 2.5 to 3.5 molar ratio (Excessive sodium, severe potassium deficiency).
High dietary potassium intake stimulates vascular endothelial nitric oxide synthase (eNOS), inducing hyperpolarization of vascular smooth muscle cells and systemic vasodilation. Furthermore, potassium promotes natriuresis (renal sodium excretion) by inhibiting the sodium-chloride cotransporter (NCC) in the renal distal convoluted tubule.
Rich Whole Food Dietary Sources of Potassium
| Food Item | Standard Serving Size | Potassium Content (mg) | Calories (kcal) | Potassium Density (mg/100 kcal) |
|---|---|---|---|---|
| Baked Russet Potato (with skin) | 1 large (299 g) | 925 mg | 290 kcal | 319 mg / 100 kcal |
| Cooked Swiss Chard | 1 cup (175 g) | 961 mg | 35 kcal | 2,746 mg / 100 kcal |
| Cooked White / Navy Beans | 1 cup (182 g) | 1,004 mg | 255 kcal | 394 mg / 100 kcal |
| Fresh Hass Avocado | 1 medium (150 g) | 728 mg | 240 kcal | 303 mg / 100 kcal |
| Cooked Spinach | 1 cup (180 g) | 839 mg | 41 kcal | 2,046 mg / 100 kcal |
| Wild Atlantic Salmon (Cooked) | 6 oz fillet (170 g) | 860 mg | 240 kcal | 358 mg / 100 kcal |
| Medium Banana | 1 medium (118 g) | 422 mg | 105 kcal | 402 mg / 100 kcal |
Clinical Imbalances: Hypokalemia versus Hyperkalemia
Serum potassium deviations alter the cardiac resting membrane potential and can trigger fatal cardiac dysrhythmias:
- Hypokalemia (< 3.5 mEq/L): Hyperpolarizes cardiac myocytes, increasing automaticity and delaying repolarization. Electrocardiographic (ECG) changes include ST-segment depression, flattened or inverted T waves, prominent U waves, and life-threatening ventricular arrhythmias (torsades de pointes, ventricular fibrillation). Common causes: loop/thiazide diuretics, severe vomiting, diarrhea, hyperaldosteronism, or refeeding syndrome.
- Hyperkalemia (> 5.0 to 5.5 mEq/L): Partially depolarizes resting membrane potential, inactivating fast voltage-gated sodium channels and slowing intracardiac conduction velocity. Sequential ECG changes: tall peaked T waves → PR interval prolongation and loss of P waves → QRS widening → "sine wave" morphology → asystole/ventricular fibrillation. Common causes: Chronic Kidney Disease (CKD), ACE inhibitors, ARBs, potassium-sparing diuretics (spironolactone), acute rhabdomyolysis, and adrenal insufficiency (Addison's disease).
Frequently Asked Questions About Potassium
Why are over-the-counter potassium supplements capped at only 99 mg?
In the United States, the Food and Drug Administration (FDA) restricts over-the-counter potassium supplements to 99 mg per dose. High-potency solid potassium chloride tablets can produce localized high concentrations in the small intestine, causing mucosal ulceration, hemorrhage, and bowel perforation. Meeting the 3,400 mg daily requirement is safely achieved through potassium-rich whole foods.
How does cooking affect the potassium content of vegetables?
Potassium is an extremely water-soluble ionic mineral. Boiling vegetables in large volumes of water leaches 50% to 75% of their potassium into the discarded cooking water. To preserve dietary potassium, prepare vegetables via steaming, microwaving, roasting, sautéing, or consuming the cooking liquid in soups and stews.
Why must patients with Chronic Kidney Disease (CKD) restrict dietary potassium?
In healthy individuals, the kidneys excrete ~90% of ingested potassium. In advanced Chronic Kidney Disease (Stage 4 and 5) or end-stage renal disease (ESRD), failing nephrons cannot clear potassium, leading to life-threatening hyperkalemic cardiac arrest. Nephrologists place these patients on strict low-potassium diets (< 2,000 mg/day) and potassium-binder medications.
Can intense exercise cause potassium depletion?
During strenuous exercise, potassium is lost in sweat (approximately 150 to 300 mg/L) and shifts into extracellular fluid during muscle repolarization. In extreme endurance events or hot weather training, prolonged sweating can contribute to total-body potassium deficits, requiring post-workout potassium repletion through fruit, coconut water, or balanced electrolyte meals.
Renal Potassium Handling in the Cortical Collecting Duct
The human kidneys filter approximately 700 to 800 mEq of potassium per day through the glomeruli. Roughly 65% is obligatorily reabsorbed in the proximal convoluted tubule, and 25% is reabsorbed in the thick ascending limb of Henle's loop via the Na+-K+-2Cl− cotransporter (NKCC2).
Precision homeostatic regulation occurs in the late distal convoluted tubule (DCT) and cortical collecting duct (CCD) through two specialized cell populations:
- Principal Cells (Potassium Secretion): Basolateral ^+/K^+$-ATPase pumps potassium into the cell while ejecting sodium. Apical Epithelial Sodium Channels (ENaC) allow sodium entry down its chemical gradient, creating a lumen-negative transepithelial potential difference (−10 to −50 mV). This negative luminal voltage draws intracellular potassium out into the tubular fluid through ROMK (Renal Outer Medullary Potassium / Kir1.1) channels and flow-activated BK (Maxi-K) channels.
- Aldosterone Stimulation: Aldosterone directly upregulates apical ENaC expression, apical ROMK density, and basolateral ^+/K^+$-ATPase activity, accelerating potassium excretion.
- Distal Tubular Flow Rate: High distal urine flow (e.g., from hydration or loop/thiazide diuretics) washes secreted potassium away from the apical membrane, maintaining a steep concentration gradient that promotes continuous potassium excretion.
- Type A Intercalated Cells (Potassium Reabsorption): During states of severe hypokalemia, apical ^+/K^+$-ATPase pumps exchange luminal potassium for intracellular protons, conserving potassium at the expense of developing metabolic alkalosis.
The Dietary Approaches to Stop Hypertension (DASH) Framework
The landmark multi-center DASH trials established that consuming a diet rich in potassium (4,700 mg/day ≈ 120 mEq/day), magnesium (500 mg/day), and calcium (1,240 mg/day) derived from fruits, vegetables, and low-fat dairy substantially reduces blood pressure:
• Hypertensive Individuals: Average reduction of −11.4 mmHg Systolic / −5.5 mmHg Diastolic.
• Normotensive Individuals: Average reduction of −3.5 mmHg Systolic / −2.1 mmHg Diastolic.
• Synergy with Sodium Restriction: Combining the high-potassium DASH diet with low sodium intake (≤ 1,500 mg/day) produced an unprecedented −13.6 mmHg systolic reduction in hypertensive patients.
Electrocardiographic (ECG) Correlation Across Serum Potassium Gradients
| Serum Potassium Level | Clinical Classification | Characteristic Electrocardiographic (ECG) Features | Life-Threatening Risks |
|---|---|---|---|
| < 2.5 mEq/L | Severe Hypokalemia | Marked ST depression, T wave flattening/inversion, massive U waves, prolonged QU interval. | Torsades de pointes, ventricular fibrillation, paralytic ileus, rhabdomyolysis. |
| 2.5 – 3.4 mEq/L | Mild-to-Moderate Hypokalemia | Decreased T wave amplitude, appearance of prominent U waves (> 1 mm). | Atrial fibrillation, ventricular premature complexes, muscle weakness. |
| 3.5 – 5.0 mEq/L | Normokalemia (Normal) | Normal upright P wave, sharp QRS complex, rounded symmetric T wave. | Optimal resting cardiac and neuromuscular membrane stability. |
| 5.5 – 6.5 mEq/L | Mild Hyperkalemia | Narrow, tall, symmetrically peaked ("tented") T waves with narrow base. | Impaired cardiac repolarization; usually asymptomatic. |
| 6.5 – 7.5 mEq/L | Moderate Hyperkalemia | PR interval prolongation, flattening and disappearance of P waves, ST elevation. | Bradycardia, sinoatrial block, atrioventricular nodal conduction blocks. |
| > 7.5 – 8.0+ mEq/L | Severe Hyperkalemia | Widening of QRS complex merging with T wave to form a classical "sine-wave" pattern. | Imminent ventricular fibrillation, pulseless electrical activity (PEA), asystolic cardiac arrest. |
The Aldosterone Escape Phenomenon and Transepithelial Voltages
In states of primary mineralocorticoid excess (such as Conn's syndrome / aldosterone-producing adenomas), continuous aldosterone stimulation initially promotes intense sodium retention and potassium wasting. However, after several days of extracellular volume expansion, the body engages aldosterone escape:
- Sodium Escape: Atrial natriuretic peptide (ANP) release and elevated renal perfusion pressure restore urinary sodium excretion to equal intake, preventing progressive edema.
- Persistent Potassium Wasting: In contrast to sodium, there is no "escape" for potassium excretion. The sustained negative lumen potential in the cortical collecting duct and elevated distal tubular flow drive continuous, unchecked potassium secretion through ROMK channels, resulting in profound, refractory hypokalemia and metabolic alkalosis.
Pseudohyperkalemia and Pre-Analytical Phlebotomy Artifacts
An elevated laboratory serum potassium result does not always reflect true in vivo hyperkalemia. Pseudohyperkalemia is an artificial in vitro elevation caused by mechanical or biological release of intracellular potassium from blood cells after phlebotomy:
• Mechanical Hemolysis: Vigorous blood aspiration through small needles, prolonged tourniquet application (> 1–2 min), fist pumping during venipuncture, or delayed centrifugal serum separation.
• Severe Thrombocytosis: Platelet counts > 500,000 to 1,000,000/μL release potassium during in vitro clot retraction (Serum K+ is elevated while Plasma K+ drawn in heparinized tubes is normal).
• Extreme Leukocytosis: White blood cell counts > 50,000 to 100,000/μL (leukemia) lead to cell fragility and potassium leakage.
• Clinical Verification: Repeat venipuncture without fist clenching, draw into a green-top (heparinized) tube, and transport immediately on wet ice for rapid plasma potassium analysis.
The 10-Point Evidence-Based Potassium Optimization Protocol
- Aim for 3,400 to 4,700 mg Daily: Target the NASEM AI (3,400 mg for men, 2,600 mg for women) or optimal DASH level (4,700 mg/day) from whole foods.
- Prioritize Potassium-Dense Foods: Incorporate baked potatoes with skin, Swiss chard, avocados, white beans, spinach, and salmon into regular meals.
- Optimize the Sodium-to-Potassium Ratio: Consume at least as many milligrams of potassium as sodium (ideal molar ratio ≤ 1.0).
- Preserve Potassium During Cooking: Steam, microwave, or roast vegetables rather than boiling them in large amounts of water to avoid leaching.
- Check Renal Function Before Supplementing: Never consume high-dose potassium supplements or salt substitutes without confirming normal baseline renal function (eGFR ≥ 60 mL/min/1.73m²).
- Monitor When Taking RAAS Blockers: Patients prescribed ACE inhibitors (lisinopril), ARBs (losartan), or aldosterone antagonists (spironolactone) must monitor serum potassium every 3 to 6 months to prevent hyperkalemia.
- Replenish Post-Exercise Electrolytes: After prolonged endurance training in high heat, consume potassium-rich recovery foods (bananas, potatoes, coconut water).
- Watch for Loop / Thiazide Diuretic Depletion: Patients taking furosemide or hydrochlorothiazide must have serum potassium monitored regularly to catch asymptomatic hypokalemia.
- Support Bone Mineral Retention: High-potassium alkaline diets rich in potassium citrate and bicarbonate precursors neutralize metabolic acid loads, reducing urinary calcium excretion and preserving bone density.
- Evaluate ECG Changes Urgently: Any acute serum potassium < 3.0 mEq/L or > 5.5 mEq/L warrants an immediate 12-lead electrocardiogram.
Detailed Clinical Potassium FAQs
Are potassium chloride salt substitutes safe for everyone?
Potassium chloride salt substitutes (e.g., Nu-Salt, NoSalt) are highly effective at lowering blood pressure in the general population by replacing dietary sodium with potassium. However, they are hazardous for individuals with Chronic Kidney Disease (CKD), heart failure, or those taking ACE inhibitors, ARBs, or potassium-sparing diuretics, where sudden potassium loads can trigger life-threatening hyperkalemia.
Why does diabetic ketoacidosis (DKA) cause total body potassium depletion despite high initial serum potassium?
In DKA, insulin deficiency and hyperosmolality shift potassium from inside cells into extracellular fluid, while metabolic acidosis further displaces potassium, creating a normal or elevated initial serum potassium reading. However, osmotic diuresis from hyperglycemia excretes massive quantities of potassium in urine. When insulin therapy is initiated, potassium rapidly re-enters cells, which can precipitate fatal hypokalemia unless potassium is proactively added to IV fluids.
How does real licorice cause severe hypokalemia and hypertension?
Natural licorice contains glycyrrhizic acid, which inhibits the renal enzyme 11-beta-hydroxysteroid dehydrogenase type 2 (11β-HSD2). Normally, 11β-HSD2 converts active cortisol into inactive cortisone inside renal collecting duct cells, protecting mineralocorticoid receptors from cortisol activation. When inhibited, high circulating cortisol over-activates mineralocorticoid receptors, causing intense pseudo-hyperaldosteronism with severe potassium wasting, metabolic alkalosis, and hypertension.
What is the relationship between serum magnesium and potassium?
Magnesium is an obligate intracellular cofactor for the ^+/K^+$-ATPase pump and acts as an intracellular blocker of ROMK potassium secretory channels in the renal collecting duct. When magnesium is deficient, ROMK channels remain open, causing unchecked renal potassium wasting that is refractory to potassium supplementation until magnesium is repleted.
How do beta-2 adrenergic agonists (like albuterol) lower serum potassium?
Beta-2 adrenergic stimulation activates adenylyl cyclase, increasing intracellular cyclic AMP (cAMP) and stimulating the ^+/K^+$-ATPase pump. This rapidly shifts extracellular potassium into skeletal muscle myocytes. High-dose nebulized albuterol is used clinically as an emergency temporizing measure to rapidly lower serum potassium in acute hyperkalemia.
Can a high-potassium diet prevent kidney stones?
Yes. Potassium-rich fruits and vegetables deliver potassium paired with organic anions (citrate, malate) that metabolize into bicarbonate in the liver. This alkalinizes the urine, increasing urinary citrate excretion. Citrate forms soluble complexes with urinary calcium, inhibiting the nucleation, aggregation, and growth of calcium oxalate kidney stones.
Cellular Potassium Translocation and Acid-Base Mechanics
The distribution of potassium between intracellular and extracellular fluid compartments is acutely modulated by systemic acid-base balance and hormonal signaling:
- Metabolic Acidosis Shifts: In mineral metabolic acidosis (e.g., hyperchloremic metabolic acidosis caused by NH4Cl or severe diarrhea), excess extracellular hydrogen ions enter cells down their concentration gradient to be buffered by intracellular proteins and phosphates. To preserve electroneutrality, potassium ions exit the cell into the extracellular space. As a clinical rule of thumb, every 0.1 unit drop in arterial pH increases serum potassium by approximately 0.4 to 0.6 mEq/L.
- Metabolic Alkalosis Shifts: Conversely, in metabolic alkalosis, hydrogen ions leave intracellular compartments, driving potassium into cells and precipitating hypokalemia.
- Insulin and Epinephrine Translocation: Postprandial insulin surges and beta-2 adrenergic stimulation (fight-or-flight signaling) activate the ^+/K^+$-ATPase pump, driving potassium into skeletal muscle and hepatic cells, preventing dangerous postprandial extracellular hyperkalemia.
Potassium Retention Across Culinary Preparation Methods
| Cooking Technique | Potassium Retention Rate | Leaching Mechanism | Recommended Culinary Use |
|---|---|---|---|
| Deep Boiling in Excess Water | 25% – 50% retained (50%–75% leached) | Water-soluble ionic K+ rapidly diffuses into discarded water. | Prescribed for CKD dialysis patients to lower potassium. |
| Steam Cooking (Steamer Basket) | 80% – 90% retained | Minimal surface contact with liquid water prevents diffusion. | Ideal for retaining potassium in broccoli, carrots, and potatoes. |
| Microwaving | 85% – 95% retained | Rapid heating with minimal added water preserves cellular minerals. | Fast, high-retention method for whole potatoes and vegetables. |
| Dry Oven Roasting / Air Frying | 90% – 98% retained | Moisture evaporation concentrates minerals within the intact food tissue. | Maximum mineral preservation for tubers and squash. |
Potassium-Binding Polymers in Advanced Renal Disease
In patients with advanced Chronic Kidney Disease (Stage 4 and 5) or heart failure who require guideline-directed medical therapy with RAAS inhibitors (ACE inhibitors, ARBs, MRAs), modern potassium-binding polymers allow patients to maintain cardioprotective medications while preventing hyperkalemia:
- Patiromer (Veltassa): A non-absorbed cross-linked polymer that binds potassium in exchange for calcium in the distal colon, increasing fecal potassium excretion and normalizing serum potassium within 4 to 7 hours.
- Sodium Zirconium Cyclosilicate (Lokelma / SZC): An inorganic crystalline zirconium silicate compound that selectively captures potassium ions in exchange for sodium and hydrogen throughout the entire gastrointestinal tract, achieving normokalemia within 1 to 2 hours of administration.